SCHEMBL9727720

SCHEMBL9727720

[c]1ccc2sc(-c3cc4ccccc4s3)cc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 2/20 0.47
HSD17B1 P14061 1/20 0.42
HSD17B2 P37059 1/20 0.42
CA2 P00918 2/20 0.41
CA1 P00915 2/20 0.41
CA9 Q16790 2/20 0.41
NQO1 P15559 1/20 0.41
NQO2 P16083 1/20 0.41
CYP2A6 P11509 4/20 0.40
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
CHRM5 P08912 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
ADRB2 P07550 1/20 0.40
ASIC3 Q9UHC3 1/20 0.39
LOXL2 Q9Y4K0 1/20 0.39
MGLL Q99685 1/20 0.39
ERN1 O75460 2/20 0.39
CYP19A1 P11511 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3807869 0.84 ESR1 (0.49) APPHSD17B1HSD17B2CA2CA1
SCHEMBL845603 0.82 APP (0.63) APPHSD17B1HSD17B2CA2CA1
SCHEMBL29732980 0.82 APP (0.63) APPHSD17B1HSD17B2CA2CA1
SCHEMBL145377 0.79 APP (0.62) APPHSD17B1HSD17B2CA2CA1
SCHEMBL731117 0.79 APP (0.53) APPHSD17B1HSD17B2CA2CA1
SCHEMBL2149612 0.78 APP (0.59) APPHSD17B1HSD17B2CA2CA1
SCHEMBL21295850 0.77 KDM4E (0.49) CYP19A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL2150464 0.76 APP (0.57) APPHSD17B1HSD17B2CA2CA1
SCHEMBL5148513 0.76 APP (0.57) APPHSD17B1HSD17B2CA2CA1
SCHEMBL27651550 0.76 APP (0.57) APPHSD17B1HSD17B2CA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5091533-A Treating allergies, cardiovascular disorders, inflammation MERCK FROSST CANADA, INC. (CA) 1992-02-25 US claimed
US-5091533-A Treating allergies, cardiovascular disorders, inflammation MERCK FROSST CANADA, INC. (CA) 1992-02-25 US disclosed
EP-0447189-A1 5-Hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors MERCK FROSST CANADA INC. (CA) 1991-09-18 EP disclosed